PTEN Loss and PD-L1 Expression of Different Histological Patterns of Prostate Cancer

被引:4
作者
Kir, Gozde [1 ]
Cecikoglu, Gozde Ecem [1 ]
Olgun, Zeynep Cagla [1 ]
Kazan, Huseyin Ozgur [2 ]
Yildirim, Asif [2 ]
机构
[1] Istanbul Medeniyet Univ, Pathol Dept, Prof Dr Suleyman Yalcin City Hosp, Istanbul, Turkey
[2] Istanbul Medeniyet Univ, Urol Dept, Prof Dr Suleyman Yalcin City Hosp, Istanbul, Turkey
关键词
Prostate cancer; PTEN; PD-L1; Architectural pattern; Cribriform pattern; IMMUNOHISTOCHEMISTRY ASSAY; RADICAL PROSTATECTOMY; ANALYTIC VALIDATION; CRIBRIFORM PATTERN; GLEASON GRADE; ADENOCARCINOMA; HETEROGENEITY; BIOPSY; FEATURES; DEATH;
D O I
10.1016/j.prp.2021.153738
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: Although several studies have evaluated PTEN loss in Prostatic Adenocarcinoma (PCa), PTEN loss correlation with different histological patterns only has a few studies. Although several studies have evaluated PD-L1 expression in PCa and its correlation with Gleason scores, as far as we know, there are no prior studies that have included a comparison between PD-L1 expression and histological patterns of PCa. This study aims to evaluate PTEN loss and PD-L1 expression by immunohistochemistry in different histological patterns of PCa. Methods: The current study included consecutive 98 radical prostatectomy specimens with 151 foci with different Gleason Grade (GG) patterns. Results: The highest frequency of PTEN loss was observed in GG4 cribriform and glomeruloid patterns (59.3%, p < 0.001). Combined score (CS) PD-L1 positivity was observed in fourteen patients (14.2%). Tumor cell (TC) and tumor-associated inflammatory cells (IC) PD-L1 positivity was observed in 10 (10.2%) and 7 (7.1%) patients. The highest frequency of PD-L1 expression was observed in the GG5 pattern, and between GG4 patterns, the irregular pattern had the highest PD-L1 positivity. Conclusions: In conclusion, in our cohort of consecutive unselected cases of prostatic carcinoma, we observed the highest PTEN loss rate in the GG4 cribriform and glomeruloid pattern and the highest PD-L1 expression rate in the GG5 and GG4 irregular patterns. These results may predict molecular differences between different histological patterns in PCa and may be used to inform a treatment decision. Future studies should investigate these differences between histological patterns of PCa to predict response to immunotherapy in larger cohorts.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Multicentric French Harmonization Study for PD-L1 IHC Testing in NSCLC
    Adam, Julien
    Rouquette, Isabelle
    Damotte, Diane
    Badoual, Cecile
    Danel, Claire
    Damiola, Francesca
    Penault-Llorca, Frederique
    Lantuejoul, Sylvie
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S11 - S12
  • [2] A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer
    Ahearn, Thomas U.
    Pettersson, Andreas
    Ebot, Ericka M.
    Gerke, Travis
    Graff, Rebecca E.
    Morais, Carlos L.
    Hicks, Jessica L.
    Wilson, Kathryn M.
    Rider, Jennifer R.
    Sesso, Howard D.
    Fiorentino, Michelangelo
    Flavin, Richard
    Finn, Stephen
    Giovannucci, Edward L.
    Loda, Massimo
    Stampfer, Meir J.
    De Marzo, Angelo M.
    Mucci, Lorelei A.
    Lotan, Tamara L.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (02):
  • [3] Multifocal prostate cancer: biologic, prognostic, and therapeutic implications
    Andreoiu, Matei
    Cheng, Liang
    [J]. HUMAN PATHOLOGY, 2010, 41 (06) : 781 - 793
  • [4] [Anonymous], 2018, ONCOTARGET
  • [5] Heterogeneity of gleason grade in multifocal adenocarcinorna of the prostate
    Arora, R
    Koch, MO
    Eble, JN
    Ulbright, TM
    Li, L
    Cheng, L
    [J]. CANCER, 2004, 100 (11) : 2362 - 2366
  • [6] Immune Characterization of the Programmed Death Receptor Pathway in High Risk Prostate Cancer
    Baas, Wesley
    Gershburg, Svetlana
    Dynda, Danuta
    Delfino, Kristin
    Robinson, Kathy
    Nie, Daotai
    Yearley, Jennifer Holmes
    Alanee, Shaheen
    [J]. CLINICAL GENITOURINARY CANCER, 2017, 15 (05) : 577 - 581
  • [7] Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
    Beer, Tomasz M.
    Kwon, Eugene D.
    Drake, Charles G.
    Fizazi, Karim
    Logothetis, Christopher
    Gravis, Gwenaelle
    Ganju, Vinod
    Polikoff, Jonathan
    Saad, Fred
    Humanski, Piotr
    Piulats, Josep M.
    Gonzalez Mella, Pablo
    Ng, Siobhan S.
    Jaeger, Dirk
    Parnis, Francis X.
    Franke, Fabio A.
    Puente, Javier
    Carvajal, Roman
    Sengelov, Lisa
    McHenry, M. Brent
    Varma, Arvind
    van den Eertwegh, Alfonsus J.
    Gerritsen, Winald
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (01) : 40 - +
  • [8] Expression of PD-L1 in Hormone-naive and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide
    Calagua, Carla
    Russo, Joshua
    Sun, Yue
    Schaefer, Rachel
    Lis, Rosina
    Zhang, Zhenwei
    Mahoney, Kathleen
    Bubley, Glenn J.
    Loda, Massimo
    Taplin, Mary-Ellen
    Balk, Steven P.
    Ye, Huihui
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (22) : 6812 - 6822
  • [9] Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy
    Choy, Bonnie
    Pearce, Shane M.
    Anderson, Blake B.
    Shalhav, Arieh L.
    Zagaja, Gregory
    Eggener, Scott E.
    Paner, Gladell P.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (10) : 1400 - 1406
  • [10] Architectural Heterogeneity and Cribriform Pattern Predict Adverse Clinical Outcome for Gleason Grade 4 Prostatic Adenocarcinoma
    Dong, Fei
    Yang, Ping
    Wang, Chaofu
    Wu, Shulin
    Xiao, Yu
    McDougal, W. Scott
    Young, Robert H.
    Wu, Chin-Lee
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (12) : 1855 - 1861